aluates Reports

$ 0.0

Automative

Monkeypox Vaccine And Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: December 2024

Report Code: QYRE-Auto-35E12460

Global Monkeypox Vaccine And Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Monkeypox Vaccine And Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35E12460

Report

December 2024

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bavarian Nordic

SIGA Technologies

Chimerix

Emergent

Gilead Sciences Inc

Monkeypox Vaccine And Treatment - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Monkeypox Vaccine And Treatment - Market

The JYNNEOS vaccine is approved for prevention of smallpox and monkeypox. It is the primary vaccine being used during this outbreak in the U.S. The ACAM2000 vaccine is an alternative to JYNNEOS. It is also approved to help protect against smallpox and monkeypox.

The global market for Monkeypox Vaccine And Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Monkeypox Vaccine And Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Monkeypox Vaccine And Treatment by region & country, by Type, and by Application.

The Monkeypox Vaccine And Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Vaccine And Treatment.

Market Segmentation

Scope of Monkeypox Vaccine And Treatment - Market Report

Report Metric	Details
Report Name	Monkeypox Vaccine And Treatment - Market
CAGR	5%
Segment by Type:	Vaccine Drugs Vaccinia Immune Globulin (VIG)
Segment by Application	Hospitals Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bavarian Nordic, SIGA Technologies, Chimerix, EMERGENT, Gilead Sciences, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Monkeypox Vaccine And Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Monkeypox Vaccine And Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Monkeypox Vaccine And Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Monkeypox Vaccine And Treatment - Market report?

Ans: The main players in the Monkeypox Vaccine And Treatment - Market are Bavarian Nordic, SIGA Technologies, Chimerix, EMERGENT, Gilead Sciences, Inc.

What are the Application segmentation covered in the Monkeypox Vaccine And Treatment - Market report?

Ans: The Applications covered in the Monkeypox Vaccine And Treatment - Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Monkeypox Vaccine And Treatment - Market report?

Ans: The Types covered in the Monkeypox Vaccine And Treatment - Market report are Vaccine, Drugs, Vaccinia Immune Globulin (VIG)

Recommended Reports

Human Vaccine Markets

Vaccine Delivery & Packaging

Emerging & Specialty Vaccines

1 Market Overview

1.1 Monkeypox Vaccine And Treatment Product Introduction

1.2 Global Monkeypox Vaccine And Treatment Market Size Forecast

1.3 Monkeypox Vaccine And Treatment Market Trends & Drivers

1.3.1 Monkeypox Vaccine And Treatment Industry Trends

1.3.2 Monkeypox Vaccine And Treatment Market Drivers & Opportunity

1.3.3 Monkeypox Vaccine And Treatment Market Challenges

1.3.4 Monkeypox Vaccine And Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Monkeypox Vaccine And Treatment Players Revenue Ranking (2023)

2.2 Global Monkeypox Vaccine And Treatment Revenue by Company (2019-2024)

2.3 Key Companies Monkeypox Vaccine And Treatment Manufacturing Base Distribution and Headquarters

2.4 Key Companies Monkeypox Vaccine And Treatment Product Offered

2.5 Key Companies Time to Begin Mass Production of Monkeypox Vaccine And Treatment

2.6 Monkeypox Vaccine And Treatment Market Competitive Analysis

2.6.1 Monkeypox Vaccine And Treatment Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Monkeypox Vaccine And Treatment Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Vaccine And Treatment as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Vaccine

3.1.2 Drugs

3.1.3 Vaccinia Immune Globulin (VIG)

3.2 Global Monkeypox Vaccine And Treatment Sales Value by Type

3.2.1 Global Monkeypox Vaccine And Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Monkeypox Vaccine And Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Monkeypox Vaccine And Treatment Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Specialty Clinics

4.1.3 Others

4.2 Global Monkeypox Vaccine And Treatment Sales Value by Application

4.2.1 Global Monkeypox Vaccine And Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Monkeypox Vaccine And Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Monkeypox Vaccine And Treatment Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Monkeypox Vaccine And Treatment Sales Value by Region

5.1.1 Global Monkeypox Vaccine And Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Monkeypox Vaccine And Treatment Sales Value by Region (2019-2024)

5.1.3 Global Monkeypox Vaccine And Treatment Sales Value by Region (2025-2030)

5.1.4 Global Monkeypox Vaccine And Treatment Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Monkeypox Vaccine And Treatment Sales Value, 2019-2030

5.2.2 North America Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Monkeypox Vaccine And Treatment Sales Value, 2019-2030

5.3.2 Europe Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Monkeypox Vaccine And Treatment Sales Value, 2019-2030

5.4.2 Asia Pacific Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Monkeypox Vaccine And Treatment Sales Value, 2019-2030

5.5.2 South America Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Monkeypox Vaccine And Treatment Sales Value, 2019-2030

5.6.2 Middle East & Africa Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Monkeypox Vaccine And Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Monkeypox Vaccine And Treatment Sales Value

6.3 United States

6.3.1 United States Monkeypox Vaccine And Treatment Sales Value, 2019-2030

6.3.2 United States Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Monkeypox Vaccine And Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Monkeypox Vaccine And Treatment Sales Value, 2019-2030

6.4.2 Europe Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Monkeypox Vaccine And Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Monkeypox Vaccine And Treatment Sales Value, 2019-2030

6.5.2 China Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Monkeypox Vaccine And Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Monkeypox Vaccine And Treatment Sales Value, 2019-2030

6.6.2 Japan Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Monkeypox Vaccine And Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Monkeypox Vaccine And Treatment Sales Value, 2019-2030

6.7.2 South Korea Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Monkeypox Vaccine And Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Monkeypox Vaccine And Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Monkeypox Vaccine And Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Monkeypox Vaccine And Treatment Sales Value, 2019-2030

6.9.2 India Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Monkeypox Vaccine And Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bavarian Nordic

7.1.1 Bavarian Nordic Profile

7.1.2 Bavarian Nordic Main Business

7.1.3 Bavarian Nordic Monkeypox Vaccine And Treatment Products, Services and Solutions

7.1.4 Bavarian Nordic Monkeypox Vaccine And Treatment Revenue (US$ Million) & (2019-2024)

7.1.5 Bavarian Nordic Recent Developments

7.2 SIGA Technologies

7.2.1 SIGA Technologies Profile

7.2.2 SIGA Technologies Main Business

7.2.3 SIGA Technologies Monkeypox Vaccine And Treatment Products, Services and Solutions

7.2.4 SIGA Technologies Monkeypox Vaccine And Treatment Revenue (US$ Million) & (2019-2024)

7.2.5 SIGA Technologies Recent Developments

7.3 Chimerix

7.3.1 Chimerix Profile

7.3.2 Chimerix Main Business

7.3.3 Chimerix Monkeypox Vaccine And Treatment Products, Services and Solutions

7.3.4 Chimerix Monkeypox Vaccine And Treatment Revenue (US$ Million) & (2019-2024)

7.3.5 EMERGENT Recent Developments

7.4 EMERGENT

7.4.1 EMERGENT Profile

7.4.2 EMERGENT Main Business

7.4.3 EMERGENT Monkeypox Vaccine And Treatment Products, Services and Solutions

7.4.4 EMERGENT Monkeypox Vaccine And Treatment Revenue (US$ Million) & (2019-2024)

7.4.5 EMERGENT Recent Developments

7.5 Gilead Sciences, Inc.

7.5.1 Gilead Sciences, Inc. Profile

7.5.2 Gilead Sciences, Inc. Main Business

7.5.3 Gilead Sciences, Inc. Monkeypox Vaccine And Treatment Products, Services and Solutions

7.5.4 Gilead Sciences, Inc. Monkeypox Vaccine And Treatment Revenue (US$ Million) & (2019-2024)

7.5.5 Gilead Sciences, Inc. Recent Developments

8 Industry Chain Analysis

8.1 Monkeypox Vaccine And Treatment Industrial Chain

8.2 Monkeypox Vaccine And Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Monkeypox Vaccine And Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Monkeypox Vaccine And Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bavarian Nordic

SIGA Technologies

Chimerix

Emergent

Gilead Sciences Inc

List of Tables

Table 1. Monkeypox Vaccine And Treatment Market Trends

Table 2. Monkeypox Vaccine And Treatment Market Drivers & Opportunity

Table 3. Monkeypox Vaccine And Treatment Market Challenges

Table 4. Monkeypox Vaccine And Treatment Market Restraints

Table 5. Global Monkeypox Vaccine And Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Monkeypox Vaccine And Treatment Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Monkeypox Vaccine And Treatment Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Monkeypox Vaccine And Treatment Product Type

Table 9. Key Companies Time to Begin Mass Production of Monkeypox Vaccine And Treatment

Table 10. Global Monkeypox Vaccine And Treatment Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Vaccine And Treatment as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Monkeypox Vaccine And Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Monkeypox Vaccine And Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Monkeypox Vaccine And Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Monkeypox Vaccine And Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Monkeypox Vaccine And Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Monkeypox Vaccine And Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Monkeypox Vaccine And Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Monkeypox Vaccine And Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Monkeypox Vaccine And Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Monkeypox Vaccine And Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Monkeypox Vaccine And Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Monkeypox Vaccine And Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Monkeypox Vaccine And Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Monkeypox Vaccine And Treatment Sales Value by Region (2019-2024) & (%)

Table 27. Global Monkeypox Vaccine And Treatment Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Monkeypox Vaccine And Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Monkeypox Vaccine And Treatment Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Monkeypox Vaccine And Treatment Sales Value, (2025-2030) & (US$ Million)

Table 31. Bavarian Nordic Basic Information List

Table 32. Bavarian Nordic Description and Business Overview

Table 33. Bavarian Nordic Monkeypox Vaccine And Treatment Products, Services and Solutions

Table 34. Revenue (US$ Million) in Monkeypox Vaccine And Treatment Business of Bavarian Nordic (2019-2024)

Table 35. Bavarian Nordic Recent Developments

Table 36. SIGA Technologies Basic Information List

Table 37. SIGA Technologies Description and Business Overview

Table 38. SIGA Technologies Monkeypox Vaccine And Treatment Products, Services and Solutions

Table 39. Revenue (US$ Million) in Monkeypox Vaccine And Treatment Business of SIGA Technologies (2019-2024)

Table 40. SIGA Technologies Recent Developments

Table 41. Chimerix Basic Information List

Table 42. Chimerix Description and Business Overview

Table 43. Chimerix Monkeypox Vaccine And Treatment Products, Services and Solutions

Table 44. Revenue (US$ Million) in Monkeypox Vaccine And Treatment Business of Chimerix (2019-2024)

Table 45. Chimerix Recent Developments

Table 46. EMERGENT Basic Information List

Table 47. EMERGENT Description and Business Overview

Table 48. EMERGENT Monkeypox Vaccine And Treatment Products, Services and Solutions

Table 49. Revenue (US$ Million) in Monkeypox Vaccine And Treatment Business of EMERGENT (2019-2024)

Table 50. EMERGENT Recent Developments

Table 51. Gilead Sciences, Inc. Basic Information List

Table 52. Gilead Sciences, Inc. Description and Business Overview

Table 53. Gilead Sciences, Inc. Monkeypox Vaccine And Treatment Products, Services and Solutions

Table 54. Revenue (US$ Million) in Monkeypox Vaccine And Treatment Business of Gilead Sciences, Inc. (2019-2024)

Table 55. Gilead Sciences, Inc. Recent Developments

Table 56. Key Raw Materials Lists

Table 57. Raw Materials Key Suppliers Lists

Table 58. Monkeypox Vaccine And Treatment Downstream Customers

Table 59. Monkeypox Vaccine And Treatment Distributors List

Table 60. Research Programs/Design for This Report

Table 61. Key Data Information from Secondary Sources

Table 62. Key Data Information from Primary Sources

Table 63. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Monkeypox Vaccine And Treatment Product Picture

Figure 2. Global Monkeypox Vaccine And Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Monkeypox Vaccine And Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Monkeypox Vaccine And Treatment Report Years Considered

Figure 5. Global Monkeypox Vaccine And Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Monkeypox Vaccine And Treatment Revenue in 2023

Figure 7. Monkeypox Vaccine And Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Vaccine Picture

Figure 9. Drugs Picture

Figure 10. Vaccinia Immune Globulin (VIG) Picture

Figure 11. Global Monkeypox Vaccine And Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Monkeypox Vaccine And Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Hospitals

Figure 14. Product Picture of Specialty Clinics

Figure 15. Product Picture of Others

Figure 16. Global Monkeypox Vaccine And Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Monkeypox Vaccine And Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Monkeypox Vaccine And Treatment Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Monkeypox Vaccine And Treatment Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Monkeypox Vaccine And Treatment Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Monkeypox Vaccine And Treatment Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Monkeypox Vaccine And Treatment Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Monkeypox Vaccine And Treatment Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Monkeypox Vaccine And Treatment Sales Value (%), (2019-2030)

Figure 29. United States Monkeypox Vaccine And Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Monkeypox Vaccine And Treatment Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Monkeypox Vaccine And Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Monkeypox Vaccine And Treatment Sales Value by Application (%), 2023 VS 2030

Figure 35. China Monkeypox Vaccine And Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

Figure 37. China Monkeypox Vaccine And Treatment Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Monkeypox Vaccine And Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Monkeypox Vaccine And Treatment Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Monkeypox Vaccine And Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Monkeypox Vaccine And Treatment Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Monkeypox Vaccine And Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Monkeypox Vaccine And Treatment Sales Value by Application (%), 2023 VS 2030

Figure 47. India Monkeypox Vaccine And Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Monkeypox Vaccine And Treatment Sales Value by Type (%), 2023 VS 2030

Figure 49. India Monkeypox Vaccine And Treatment Sales Value by Application (%), 2023 VS 2030

Figure 50. Monkeypox Vaccine And Treatment Industrial Chain

Figure 51. Monkeypox Vaccine And Treatment Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Smallpox Vaccine Market Research Report 2024

Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chickenpox Varicella Vaccine Market

Global Monkeypox Virus Detection Kit Market Research Report 2025

Monkeypox Virus Detection Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monkeypox Virus Test Kits Market Research Report 2025

Global Monkeypox Diagnostic Kit Market Research Report 2024

Global Monkeypox Vaccine Market Research Report 2025

Global Monkeypox Virus Real time PCR Kit Market Research Report 2025

Global Monkeypox Test Kit Market Research Report 2024

Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025

Global Poxviridae Infections Drug Market Research Report 2025

Viral Vector and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monkeypox Virus Antigen Detection Kit Market Research Report 2024

JE Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monkeypox Virus Nucleic Acid Detection Kit Fluorescent PCR Market Research Report 2024

Global Monkeypox Virus Real Time PCR Test Kit Market Research Report 2025

Coxsackievirus Infections Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions